Israeli hospital seeks China funding for lab-grown kidneys

scmp.com

An Israeli hospital is seeking funding, including from China, to advance its lab-grown kidney technology into clinical trials. Sheba Medical Centre and Tel Aviv University have successfully grown a synthetic kidney organoid that survived over 34 weeks, a significant breakthrough in regenerative medicine. This technology could revolutionize disease modeling and drug testing. The project lead expressed optimism, noting the organoid's secreted biomolecules may help repair damaged kidneys, potentially leading to new treatments.


With a significance score of 5.6, this news ranks in the top 0.5% of today's 27764 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: